Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects. 2021

Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
School of Biotechnology, Presidency University (2nd Campus), Kolkata 700156, West Bengal, India.

Withania somnifera (L.) Dunal (Solanaceae) has been used as a traditional Rasayana herb for a long time. Traditional uses of this plant indicate its ameliorative properties against a plethora of human medical conditions, viz. hypertension, stress, diabetes, asthma, cancer etc. This review presents a comprehensive summary of the geographical distribution, traditional use, phytochemistry, and pharmacological activities of W. somnifera and its active constituents. In addition, it presents a detailed account of its presence as an active constituent in many commercial preparations with curative properties and health benefits. Clinical studies and toxicological considerations of its extracts and constituents are also elucidated. Comparative analysis of relevant in-vitro, in-vivo, and clinical investigations indicated potent bioactivity of W. somnifera extracts and phytochemicals as anti-cancer, anti-inflammatory, apoptotic, immunomodulatory, antimicrobial, anti-diabetic, hepatoprotective, hypoglycaemic, hypolipidemic, cardio-protective and spermatogenic agents. W. somnifera was found to be especially active against many neurological and psychological conditions like Parkinson's disease, Alzheimer's disease, Huntington's disease, ischemic stroke, sleep deprivation, amyotrophic lateral sclerosis, attention deficit hyperactivity disorder, bipolar disorder, anxiety, depression, schizophrenia and obsessive-compulsive disorder. The probable mechanism of action that imparts the pharmacological potential has also been explored. However, in-depth studies are needed on the clinical use of W. somnifera against human diseases. Besides, detailed toxicological analysis is also to be performed for its safe and efficacious use in preclinical and clinical studies and as a health-promoting herb.

UI MeSH Term Description Entries
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D061214 Patient Safety Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers. Patient Safeties,Safeties, Patient,Safety, Patient
D018517 Plant Roots The usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990) Plant Bulbs,Plant Root,Bulb, Plant,Bulbs, Plant,Plant Bulb,Root, Plant,Roots, Plant

Related Publications

Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
January 2023, Frontiers in pharmacology,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
January 2015, Ayu,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
January 2022, Frontiers in pharmacology,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
April 2021, Journal of ethnopharmacology,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
January 2015, Biotechnology & genetic engineering reviews,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
January 2015, Ayu,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
October 2012, Plant cell reports,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
June 2023, Journal of food and drug analysis,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
November 2017, Journal of dietary supplements,
Subhabrata Paul, and Shreya Chakraborty, and Uttpal Anand, and Swarnali Dey, and Samapika Nandy, and Mimosa Ghorai, and Suchismita Chatterjee Saha, and Manoj Tukaram Patil, and Ramesh Kandimalla, and Jarosław Proćków, and Abhijit Dey
February 2009, Journal of integrative plant biology,
Copied contents to your clipboard!